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Background.— Abdominal aortic aneurysm (AAA) remains asymp-
utive patients admitted for AMI in our intensive care unit using a
portable TTE system (Vividi, General electric). AAA was deﬁned by
a transverse diameter≥ 30mm.
Results.— One hundred and ﬁfty-two patients were enrolled (mean
age 65± 14 years old, 78% of male). Measurement of the size of
the abdominal aorta was feasible in 93% (10 patients had poor
echogenicity) and time duration was 3± 1minute. Interobserver
variability between cardiologists was good (1.7± 1mm). Eight
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elderly patients in regard to the simplicity, inocuity and availabilitytomatic for many years but often revealed dramatically (inaugural
rupture). Its relatively low prevalence in the general population
(5.5% of men over 65 years) implies speciﬁc target population
screening. Patients with acutemyocardial infarction (AMI) represent
a high-risk population in which screening for other atherosclerotic
locations is recommended but is still often neglected. We aimed to
evaluate the feasibility of AAA screening during routine transtho-
racic echocardiography (TTE) in patients with AMI using a portable
echocardiography system and to determine the prevalence of AAA
in this population.
Methods.— We prospectively measured the size of the abdominal
aorta at the end of a regular TTE performed at bedside in consec-
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1875-2136/$ — see front matteratients had an AAA (5.2%) and prevalence increases with age, 8.7%
fter 60 years, 10.3% after 65 years. No patient below 50 years old
ad an AAA.
onclusion.— In patients admitted for AMI, screening for AAA dur-
ng TTE using a portable TTE system was fast and highly feasible.
espite a striking low prevalence of AAA in this high cardiovas-
ular risk population, analyse of the abdominal aorta should be
ecommended during TTE (‘‘one cardiovascular shot’’) especially inf the present screening.
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